Damaj, M I <br/><br/>
Calcium-acting drugs modulate expression and development of chronic tolerance to nicotine-induced antinociception in mice.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Nov 2005 
 - 959-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0022-3565 
<br/><br/><label>Standard No.: </label>10.1124/jpet.105.092460  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine--analogs & derivatives<br/>3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester--pharmacology<br/>Analgesics<br/>Animals<br/>Calcium--physiology<br/>Calcium Channel Agonists--pharmacology<br/>Calcium Channel Blockers--pharmacology<br/>Calcium Channels, L-Type--drug effects<br/>Calcium Signaling--drug effects<br/>Calcium-Calmodulin-Dependent Protein Kinase Type 2<br/>Calcium-Calmodulin-Dependent Protein Kinases--antagonists & inhibitors<br/>Drug Tolerance<br/>Enzyme Activation--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Injections, Spinal<br/>Male<br/>Mice<br/>Nicotine--pharmacology<br/>Nicotinic Agonists--pharmacology<br/>Nimodipine--pharmacology<br/>Pain Measurement--drug effects<br/>Reaction Time--drug effects<br/>Spinal Cord--drug effects<br/>Verapamil--pharmacology